Circumvent the Tariff challenges with an agile supply chain Consulting
Supply Chain Ecosystem Analysis now part of DBMR Reports
North America Computed Tomography Devices Market
Market Size in USD Billion
CAGR :
%
USD
1.67 Billion
USD
2.60 Billion
2024
2032
Forecast Period
2025 –2032
Market Size(Base Year)
USD
1.67 Billion
Market Size (Forecast Year)
USD
2.60 Billion
CAGR
5.65
%
Major Markets Players
Medtronic
Scanco Medical AG
Danaher
FUJIFILM Holdings Corporation
and more
North America Computed Tomography Devices Market Segmentation, By Product Type (Low Slice CT Scanner (<64 Slices), Medium Slice CT Scanner (64 Slices) and High Slice CT Scanner (>64 Slices)), Application (Cardiovascular Applications, Abdomen and Pelvic Application, Pulmonary Angiogram, Neurovascular Application, Spinal Application, Musculoskeletal Application and Oncology), End-User (Hospitals and Diagnostics Centres) - Industry Trends and Forecast to 2032
North America Computed Tomography Devices Market Size
The North America computed tomography devices market size was valued at USD 1.67 billion in 2024 and is expected to reach USD 2.60 billion by 2032,at a CAGR of 5.65% during the forecast period
The market growth is primarily driven by the increasing prevalence of chronic and lifestyle-related diseases, rising demand for early and accurate diagnostic imaging, and ongoing technological advancements in CT imaging systems, including AI integration and low-dose radiation techniques
In addition, expanding healthcare infrastructure, favorable reimbursement policies, and growing adoption of advanced imaging solutions in hospitals, diagnostic centers, and specialty clinics are positioning CT devices as essential diagnostic tools in the region. These combined factors are accelerating the deployment of CT systems, thereby significantly propelling the market’s growth
North America Computed Tomography Devices Market Analysis
Computed tomography (CT) devices, providing cross-sectional imaging for precise diagnosis and treatment planning, are increasingly essential components of modern medical diagnostics in hospitals and diagnostic centers due to their high imaging accuracy, speed, and integration with advanced imaging software and AI-assisted tools
The rising demand for CT devices is primarily driven by the growing prevalence of chronic diseases, increasing need for early and accurate diagnosis, and technological advancements such as low-dose imaging, AI-enabled reconstruction, and multi-slice CT systems
The U.S. dominated the North America computed tomography devices market with the largest revenue share of 88.5% in 2024, characterized by advanced healthcare infrastructure, high healthcare expenditure, and a strong presence of leading imaging equipment manufacturers, with substantial adoption of high-slice CT scanners (>64 slices) in hospitals and diagnostic centers, supported by innovations in cardiovascular, neurovascular, and oncology imaging applications
Canada is expected to be the fastest-growing country in the North America CT devices market during the forecast period due to increasing investments in healthcare infrastructure, rising patient awareness, and growing demand for advanced diagnostic imaging solutions
High-slice CT scanners (>64 slices) dominated the North America CT devices market with a market share of 44.8% in 2024, driven by their superior imaging speed, high resolution, and versatility across cardiovascular, neurovascular, and oncology applications in hospital and diagnostic center settings
Report Scope and North America Computed Tomography Devices Market Segmentation
Attributes
North America Computed Tomography Devices Key Market Insights
Segments Covered
By Product Type: Low Slice CT Scanner (<64 Slices), Medium Slice CT Scanner (64 Slices) and High Slice CT Scanner (>64 Slices
By Application: Cardiovascular Applications, Abdomen and Pelvic Application, Pulmonary Angiogram, Neurovascular Application, Spinal Application, Musculoskeletal Application and Oncology
Growth in Outpatient and Diagnostic Center Installations
Value Added Data Infosets
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, pricing analysis, brand share analysis, consumer survey, demography analysis, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.
North America Computed Tomography Devices Market Trends
Advancements in AI-Assisted Imaging and Multi-Slice CT Systems
A significant and accelerating trend in the North America CT devices market is the growing integration of artificial intelligence (AI) with multi-slice CT systems, enhancing imaging accuracy, workflow efficiency, and diagnostic capabilities
For instance, instance of Siemens Healthineers’ AI-Rad Companion can automatically analyze CT scans and provide preliminary diagnostic insights, assisting radiologists in decision-making
AI integration in CT devices enables features such as automated image reconstruction, anomaly detection, and predictive analytics for patient outcomes, improving scan reliability and reducing human error
The seamless combination of multi-slice CT systems and AI platforms allows centralized management of imaging protocols, data sharing, and reporting across hospital networks, creating a more streamlined radiology workflow
This trend toward more intelligent, high-resolution, and automated CT systems is reshaping radiology expectations. Consequently, companies such as GE Healthcare are developing AI-enabled CT scanners with advanced reconstruction algorithms and automated cardiac and neurovascular imaging analysis
The demand for CT devices offering AI-assisted imaging and high-slice capabilities is growing rapidly across hospitals and diagnostic centers, as healthcare providers increasingly prioritize efficiency, accuracy, and comprehensive diagnostic functionality
North America Computed Tomography Devices Market Dynamics
Driver
Rising Demand Due to Growing Chronic Diseases and Diagnostic Imaging Needs
The increasing prevalence of chronic diseases, cancer, and cardiovascular conditions, combined with the need for early and accurate diagnosis, is a major driver for the heightened demand for CT devices
For instance, instance of Canon Medical Systems introducing advanced high-slice CT scanners with enhanced cardiac imaging capabilities to support early detection of heart disease
As healthcare providers aim to improve patient outcomes and diagnostic precision, CT devices offer features such as high-resolution imaging, rapid scan times, and AI-assisted analysis, providing a compelling upgrade over conventional imaging modalities
Furthermore, the expanding healthcare infrastructure and rising patient awareness in the U.S. and Canada are making CT systems an integral component of diagnostic workflows in hospitals and imaging centers
The convenience of faster imaging, reduced scan times, and the ability to perform multi-organ imaging in a single session are key factors propelling CT device adoption in clinical settings. The trend toward outpatient imaging expansion and advanced diagnostic centers further contributes to market growth
Restraint/Challenge
High Equipment Costs and Regulatory Compliance Hurdles
The relatively high acquisition and maintenance costs of advanced CT systems, particularly high-slice scanners, pose a significant challenge to broader market penetration, especially for smaller diagnostic centers
For instance, instance of Medtronic highlighting budgetary constraints in smaller clinics delaying procurement of multi-slice CT systems despite clinical demand
Addressing these cost concerns through financing options, service contracts, and scalable solutions is crucial for expanding market reach. In addition, regulatory compliance and rigorous safety standards for radiation exposure present hurdles for manufacturers and healthcare providers
The need for regular software updates, training of radiology staff, and adherence to FDA and Health Canada guidelines can slow adoption rates, particularly for newly launched high-slice CT systems
While costs and compliance challenges are gradually being managed through innovative financing, modular system designs, and AI-driven automation reducing operational burden, the high capital expenditure and regulatory complexities can still hinder widespread adoption in smaller or budget-constrained healthcare facilities
North America Computed Tomography Devices Market Scope
The market is segmented on the basis of product type, application, and end-user.
By Product Type
On the basis of product type, the North America CT devices market is segmented into Low Slice CT Scanner (<64 Slices), Medium Slice CT Scanner (64 Slices), and High Slice CT Scanner (>64 Slices). The High Slice CT Scanner segment dominated the market with the largest revenue share of 44.8% in 2024, driven by its superior imaging speed, high-resolution capabilities, and versatility across multiple clinical applications. Hospitals and diagnostic centers prefer high-slice scanners for complex procedures such as cardiovascular, neurovascular, and oncology imaging, as these systems reduce scan times and improve diagnostic accuracy. The demand is further fueled by AI integration, which enhances image reconstruction, anomaly detection, and workflow efficiency. High-slice CT scanners are increasingly adopted in large hospitals and specialty diagnostic centers, where precision and speed are critical for patient outcomes. The segment’s dominance is also supported by continuous technological innovations, such as low-dose imaging and advanced software tools, enhancing their clinical appeal.
The Low Slice CT Scanner (<64 Slices) segment is expected to witness the fastest growth rate from 2025 to 2032, driven by rising demand in smaller hospitals, outpatient clinics, and diagnostic centers. These scanners offer a cost-effective solution for routine imaging, balancing affordability with sufficient diagnostic performance. Low-slice systems are particularly suitable for budget-conscious facilities or regions with moderate patient volumes, providing essential imaging capabilities without the high capital expenditure of high-slice systems. Their smaller footprint and lower maintenance requirements also contribute to their growing adoption. In addition, manufacturers are increasingly developing compact, user-friendly models that enable easy installation and operation, further expanding their market penetration. The growing trend toward decentralized and outpatient diagnostic imaging is expected to accelerate this segment’s growth.
By Application
On the basis of application, the market is segmented into cardiovascular applications, abdomen and pelvic applications, pulmonary angiogram, neurovascular applications, spinal applications, musculoskeletal applications, and oncology. The Oncology application segment dominated the market in 2024, accounting for the largest revenue share, due to the increasing prevalence of cancer and the critical need for precise tumor detection, staging, and treatment planning. High-resolution and multi-slice CT scanners are widely used in oncology for accurate imaging of soft tissues, guiding biopsy procedures, and monitoring treatment response. Integration with AI-assisted imaging enhances lesion detection and volumetric analysis, further improving diagnostic outcomes. Hospitals and specialized cancer centers prefer CT devices for oncology applications as they provide comprehensive, non-invasive imaging solutions. The demand is also driven by rising awareness of early cancer detection and routine screening protocols.
The Cardiovascular Applications segment is expected to witness the fastest growth rate during 2025–2032, fueled by rising prevalence of heart disease and demand for precise cardiac imaging. Multi-slice CT scanners are increasingly employed for coronary artery imaging, calcium scoring, and pre-surgical planning, offering rapid and accurate assessments. The integration of AI in cardiac imaging helps reduce artifacts, optimize image quality, and enable automated analysis of complex cardiovascular structures. Growing adoption in both hospitals and diagnostic centers, along with increasing awareness of early cardiovascular disease detection, is expected to drive rapid market expansion. In addition, minimally invasive and outpatient cardiac imaging procedures are contributing to this segment’s growth.
By End-User
On the basis of end-user, the North America CT devices market is segmented into hospitals and diagnostic centers. The Hospitals segment dominated the market in 2024 due to the availability of advanced infrastructure, large patient volumes, and a strong preference for high-slice and multi-purpose CT systems capable of handling diverse clinical applications. Hospitals rely on CT imaging for routine diagnostics, emergency care, oncology, cardiovascular, and neurovascular assessments, driving demand for versatile and high-performance CT devices. The presence of leading imaging equipment manufacturers and availability of technical expertise further support the adoption of CT devices in hospitals.
The Diagnostic Centers segment is expected to witness the fastest growth rate from 2025 to 2032, driven by the rising trend of outpatient diagnostics, preventive health check-ups, and specialized imaging centers. Diagnostic centers increasingly invest in medium- and low-slice CT scanners to offer cost-effective yet high-quality imaging services. The growing patient preference for convenient, non-hospital-based diagnostic services and the expansion of insurance coverage for outpatient imaging further accelerate market growth in this segment. Manufacturers are also targeting this segment with compact, easy-to-maintain CT solutions, boosting adoption across North America.
North America Computed Tomography Devices Market Regional Analysis
The U.S. dominated the North America CT devices market with the largest revenue share of 88.5% in 2024, characterized by advanced healthcare infrastructure, high healthcare expenditure, and a strong presence of leading imaging equipment manufacturers, with substantial adoption of high-slice CT scanners (>64 slices) in hospitals and diagnostic centers, supported by innovations in cardiovascular, neurovascular, and oncology imaging applications
Healthcare providers in the region highly value the accuracy, speed, and multi-application capabilities offered by high-slice and AI-integrated CT scanners, enabling precise diagnosis and improved patient outcomes
This widespread adoption is further supported by advanced healthcare infrastructure, high healthcare expenditure, and the presence of leading imaging equipment manufacturers, establishing CT devices as essential tools in hospitals and diagnostic centers across the region
U.S. Computed Tomography Devices Market Insight
The U.S. CT devices market captured the largest revenue share in 2024 within North America, driven by the rising prevalence of chronic diseases, cancer, and cardiovascular conditions requiring advanced diagnostic imaging. Hospitals and diagnostic centers are increasingly prioritizing high-slice and AI-integrated CT scanners to improve imaging accuracy, speed, and patient outcomes. The adoption of multi-slice CT systems, combined with AI-assisted reconstruction and automated analysis, further propels market growth. In addition, the U.S. benefits from advanced healthcare infrastructure, high healthcare expenditure, and the presence of leading imaging equipment manufacturers, supporting rapid deployment of CT systems. The growing trend of outpatient imaging centers and preventive health check-ups is also contributing to the market expansion.
Canada Computed Tomography Devices Market Insight
The Canada CT devices market is expected to grow at a substantial CAGR during the forecast period, fueled by increasing investments in healthcare infrastructure and rising awareness of early disease detection. Canadian hospitals and diagnostic centers are progressively adopting medium- and high-slice CT scanners to meet clinical demands for cardiovascular, oncology, and neurovascular imaging. Government initiatives promoting healthcare modernization and improved access to diagnostic services are supporting the expansion of CT device installations. Moreover, the focus on outpatient diagnostic centers and preventive care is accelerating adoption across the country. Integration of AI and advanced imaging software is further enhancing the utility of CT systems in Canadian healthcare facilities.
Mexico Computed Tomography Devices Market Insight
The Mexico CT devices market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by increasing healthcare investments and rising demand for diagnostic imaging in hospitals and specialty centers. The adoption of cost-effective low- and medium-slice CT scanners is gaining traction in urban and semi-urban areas. Growing awareness of early disease diagnosis, combined with government programs supporting healthcare access, is encouraging the deployment of CT systems. Mexico’s expanding private healthcare sector, alongside partnerships with leading imaging equipment manufacturers, is contributing to market growth. In addition, rising demand for multi-application imaging capabilities across oncology, cardiovascular, and neurovascular applications supports adoption of modern CT devices.
North America Computed Tomography Devices Market Share
The North America Computed Tomography Devices industry is primarily led by well-established companies, including:
GE Healthcare (U.S.)
Siemens Healthineers AG (Germany)
Koninklijke Philips N.V., (Netherlands)
CANON MEDICAL SYSTEMS CORPORATION (Japan)
NeuroLogica Corp (U.S.)
Ryoei USA (U.S.)
PrizMed imaging (U.S.)
North Star Imaging Inc (U.S.)
United Imaging Healthcare Co., Ltd. (U.S.)
Xoran Technologies, LLC. (U.S.)
CurveBeam (U.S.)
Stryker (U.S.)
Exact Metrology (U.S.)
Pinnacle X-Ray Solutions (U.S.)
Applied Technical Services Inc (U.S.)
Jesse Garant Metrology Center (Canada)
Micro-X (Australia)
Thermo Fisher Scientific, Inc. (U.S.)
PerkinElmer (U.S.)
Bruker (U.S.)
What are the Recent Developments in North America Computed Tomography Devices Market?
In May 2025, GE HealthCare received FDA 510(k) clearance for its new hybrid imaging system, the Aurora, along with its integrated deep learning software, Clarify DL. This nuclear medicine SPECT/CT scanner combines single-photon emission computed tomography (SPECT) and computed tomography (CT) technologies to deliver sharper, more precise imaging across clinical specialties
In March 2025, Siemens Healthineers announced that its Naeotom Alpha class of photon-counting computed tomography (CT) scanners received FDA clearance. This product class includes the Naeotom Alpha.Pro, a second dual-source CT scanner, and the Naeotom Alpha.Prime, the world’s first single-source scanner with photon-counting CT technology
In December 2024, United Imaging Healthcare introduced the uCT 780, a 160-slice CT scanner equipped with a fully integrated Z-Detector and fast rotation speed of 0.3 seconds. The system aims to deliver superior diagnostics with low-dose imaging capabilities
In November 2023, Canon Medical Systems introduced the Aquilion ONE / GENESIS Edition CT scanner. This system features advanced AI-enhanced reconstruction technology, offering improved image quality and reduced radiation dose
In November 2021, GE Healthcare launched the Revolution Apex CT platform, featuring the world's fastest gantry rotation time of 0.23 seconds per rotation and 19.5 millisecond effective temporal resolution. This modular and scalable system aims to enhance cardiac imaging capabilities and improve workflow efficiency
SKU-1435
Get online access to the report on the World's First Market Intelligence Cloud
Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
Claudio Rondena
Group Business Development & Strategic Marketing Director, C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice.
Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough.
Your work is much appreciated.
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics,
Ipsen Biopharm Limited
We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.
Competition Analyst,
Basler Web
I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.
Marketing Director,
Buhler Group
It was indeed a good experience, would definitely recommend and come back for future prospects.
COO,
A global leader providing Drug Delivery Services
DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.
Marketing Director,
Philips Healthcare
The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.
Product manager,
Fujifilms
Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
Investor relations,
GE Healthcare
Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.
Market Analyst,
Medincell
We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.
Andrew - Senior Global Marketing Manager,
Medtronic (US)
I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.
Amarildo - Manager, Global Strategic Alignment
MasterCard
We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.
Tor Hammer
Green Nexus LLc
Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects
I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying.
Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.
Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)
Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future